PURPOSE To provide guidance regarding best practices in the prevention and
management of medication-related osteonecrosis of the jaw (MRONJ) in patients with …

Objective The main aim is to identify, by means of different imaging modalities, the early
bone changes in patients “at risk” and in stage 0 MRONJ. Materials and methods A search of …

Medication-related osteonecrosis of the jaw (MRONJ), a severe side effect caused by
antiresorptive antiangiogenic medication, particularly bisphosphonates (BPs), has become a …

Tooth extraction is a risk factor for the development of osteonecrosis of the jaw following
treatment with antiresorptive drugs (ARDs), but not all extraction sites develop this …

Objective To identify local radiographic risk factors for Medication‐Related Osteonecrosis of
the Jaws (MRONJ) in osteoporotic patients treated with antiresorptive drugs (ARD) and …

Background: Bisphosphonate-associated osteonecrosis of the jaws (MRONJ/BP-
ONJ/BRONJ) is a commonly seen disease. During recent decades, major advances in …

Objective This cross-sectional study aimed to explore potential jawbone changes secondary
to bisphosphonate (BP) treatment of osteoporosis using digital panoramic and periapical …

Objectives To compare the computed tomography (CT) features of mandibular cancellous
and cortical bones between patients with bisphosphonate (BP) administration and those …

Background: To assess multimodal imaging features of medication-related osteonecrosis of
the jaw (MRONJ) and to analyze the differences between oral and parenteral routes of …

Objectives The purpose of this study was to clarify which panoramic radiographic features
can predict the development of bisphosphonate-related osteonecrosis of the jaw (BRONJ) …